Work

An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck

Year: 2019

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-019-02372-2

Authors: Ashley Pinette, Elizabeth McMichael, Nicholas B. Courtney, Megan Duggan, Brooke N. Benner, Fouad Choueiry, Lianbo Yu, David Abood, Thomas A. Mace, William E. Carson

Institutions: The Ohio State University, The Ohio State University Wexner Medical Center

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: DEVELOPMENT OF NOVEL CORRELATIVE STUDIES FOR A PHASE I, G1705275566, G3710688305, G4708969133, G6576247489, G9000046068, G9000117982, G9000137146, G9000266250, G9000336047, Cancer Center Support Grant

OpenAlex ID: W2963215846

FWCI: 1.762

Cites: 35

Cited by: 39

Related to: 10